Pressure BioSciences, Inc. (PBIO) Recently Awarded $7 Price Target
RedChip analyst, Joe Blanksenship, MBA, awarded Pressure BioSciences a $7.00 price target and rated their stock a “Speculative Buy” following the company's Q2 2007 report. In the research report, the analyst stated, “Pressure Biosciences, Inc. continues on its path to commercialization with its pressure cycling technology (“PCT”) used in sample preparation across a broad range of life-sciences applications.” The Company reported the sale of four Barocycler NEP3229 PCT Sample Preparation Systems compared to the one sold in the same period last year. $202,127 was announced as the total revenue for the quarter, which is approximately 7x the amount from Q2 2006.…